“Resultados alentadores”: una molécula innovadora podría disminuir la carga de una bacteria que genera una enfermedad que afecta especialmente a niños

Scientists from the Institute of Agrobiotechnology and Molecular Biology (Iabimo) and the Veterinary Pathology Institute (Ipvet) announced a promising breakthrough in combating the Síndrome Urémico Hemolítico, a severe disease primarily affecting children, caused by the Escherichia coli enterohemorrágica (EHEC) O157:H7 bacteria, typically found in cattle. This innovative molecule aims to significantly reduce the bacterial load, potentially preventing numerous cases of the disease. This development is crucial as it targets a major health threat linked to foodborne illnesses, particularly in communities reliant on cattle farming.